BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 659607)

  • 1. Neurodiagnostic abnormalities in patients with acute renal failure.
    Cooper JD; Lazarowitz VC; Arieff AI
    J Clin Invest; 1978 Jun; 61(6):1448-55. PubMed ID: 659607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down-regulation of PTH/PTHrP receptor in the kidney of patients with renal impairment.
    Chen J; Zhang J; Lin S
    Chin Med J (Engl); 1998 Jan; 111(1):24-7. PubMed ID: 10322647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiologic trend changes in acute renal failure--a tertiary center experience from South India.
    Jayakumar M; Prabahar MR; Fernando EM; Manorajan R; Venkatraman R; Balaraman V
    Ren Fail; 2006; 28(5):405-10. PubMed ID: 16825090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoreactive parathyroid hormones in the circulation and cerebrospinal fluid from patients with renal failure: possible restriction of parathyroid hormone by the blood-brain barrier.
    Hironaka T; Morimoto S; Fukuo K; Koh E; Imanaka S; Sumida T; Onishi T; Kumahara Y
    Bone Miner; 1987 Sep; 2(6):487-94. PubMed ID: 3505771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in the electroencephalogram in acute uremia. Effects of parathyroid hormone and brain electrolytes.
    Guisado R; Arieff AI; Massry SG; Lazarowitz V; Kerian A
    J Clin Invest; 1975 Apr; 55(4):738-45. PubMed ID: 235562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of parathyroid hormone and uremia on peripheral nerve calcium and motor nerve conduction velocity.
    Goldstein DA; Chui LA; Massry SG
    J Clin Invest; 1978 Jul; 62(1):88-93. PubMed ID: 659642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is skeletal response to parathyroid hormone abnormal in experimental renal failure?
    Patel S; Hsu CH
    J Lab Clin Med; 1988 Sep; 112(3):387-93. PubMed ID: 3411200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of polyneuropathy severity in chronic renal failure patients on continuous ambulatory peritoneal dialysis or on maintenance hemodialysis].
    Janda K; Stompór T; Gryz E; Szczudlik A; Drozdz M; Kraśniak A; Sułowicz W
    Przegl Lek; 2007; 64(6):423-30. PubMed ID: 18159852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidative stress is increased in critically ill patients with acute renal failure.
    Himmelfarb J; McMonagle E; Freedman S; Klenzak J; McMenamin E; Le P; Pupim LB; Ikizler TA; The PICARD Group
    J Am Soc Nephrol; 2004 Sep; 15(9):2449-56. PubMed ID: 15339994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parathyroidectomy as a therapeutic tool for targeting the recommended NKF-K/DOQI ranges for serum calcium, phosphate and parathyroid hormone in dialysis patients.
    Mazzaferro S; Pasquali M; Farcomeni A; Vestri AR; Filippini A; Romani AM; Barresi G; Pugliese F
    Nephrol Dial Transplant; 2008 Jul; 23(7):2319-23. PubMed ID: 18281320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Acute renal insufficiency caused by burn injury].
    Zogović J; Mladenović Lj
    Srp Arh Celok Lek; 1996; 124(9-10):241-5. PubMed ID: 9102856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Water immersion-induced alterations of plasma atrial natriuretic peptide level and its relationship to the renin-angiotensin-aldosterone system and vasopressin secretion in acute and chronic renal failure.
    Kokot F; Grzeszczak W; Zukowska-Szczechowska E; Wiecek A
    Clin Nephrol; 1989 May; 31(5):247-52. PubMed ID: 2525441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of NKF-K/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease: changes of clinical practices and their effects on outcomes and quality standards in three haemodialysis units.
    Arenas MD; Alvarez-Ude F; Gil MT; Soriano A; Egea JJ; Millán I; Amoedo ML; Muray S; Carretón MA
    Nephrol Dial Transplant; 2006 Jun; 21(6):1663-8. PubMed ID: 16464885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors modulating cytosolic calcium. Role in lipid metabolism and cardiovascular morbidity and mortality in peritoneal dialysis patients.
    Gadallah MF; el-Shahawy M; Andrews G; Ibrahim M; Ramdeen G; Hanna D; Gorospe W; Morkos A; Abbassian M; Moles K
    Adv Perit Dial; 2001; 17():29-36. PubMed ID: 11510292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma human brain natriuretic peptide in chronic renal failure.
    Akiba T; Tachibana K; Togashi K; Hiroe M; Marumo F
    Clin Nephrol; 1995 Nov; 44 Suppl 1():S61-4. PubMed ID: 8608666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parathyroid function after successful renal transplantation.
    Botha JF; Botha JR
    S Afr J Surg; 1997 Aug; 35(3):113-6. PubMed ID: 9429326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intradialytic changes of serum magnesium and their relation to hypotensive episodes in hemodialysis patients on different dialysates.
    Elsharkawy MM; Youssef AM; Zayoon MY
    Hemodial Int; 2006 Oct; 10 Suppl 2():S16-23. PubMed ID: 17022745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early markers of renal injury in predicting outcome in thermal burn patients.
    Sabry A; Wafa I; El-Din AB; El-Hadidy AM; Hassan M
    Saudi J Kidney Dis Transpl; 2009 Jul; 20(4):632-8. PubMed ID: 19587506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropathy, axonal Na+/K+ pump function and activity-dependent excitability changes in end-stage kidney disease.
    Krishnan AV; Phoon RK; Pussell BA; Charlesworth JA; Bostock H; Kiernan MC
    Clin Neurophysiol; 2006 May; 117(5):992-9. PubMed ID: 16516547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.